FeelGood vs Hims: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit TrimRx - our featured pick→or find your match

Hims beats FeelGood overall, scoring 7.9/10 vs 7/10. FeelGood is more affordable at $149/mo vs $199/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.

A side-by-side look at FeelGood and Hims to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

FeelGood

#47 of 53

7/10

Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.

Visit FeelGood

Higher Rated

Hims

#9 of 53

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

Feature	FeelGood	Hims
Our Score	7/10	7.9/10
Starting Price	$149/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors
Ranking	#47	#9
Get started	Visit FeelGood	Visit Hims

Pros & Cons Compared

FeelGood

Pros

+Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
+Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients, a non-injectable route only a handful of platforms provide
+LegitScript-approved, independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
+Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included

Cons

−Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake
−$149 is a 'starting' price (dose-escalating), not flat across all doses, your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
−Brand-name 'original' semaglutide injection at $1,999/mo is far above market, NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
−No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site, thin corporate and clinical transparency
−Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
−Compounded GLP-1s are not FDA-approved (none are), and FeelGood offers compounded semaglutide only, no tirzepatide

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Our Verdict

Hims edges out FeelGood with a score of 7.9/10 vs 7/10. If budget is your priority, FeelGood starts at $149/mo compared to Hims's $199/mo. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither FeelGood nor Hims feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review